FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 323:52-54 July 5, 1990 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rudman, D Related Article by Vance, M. L. PubMed Citation

In addition to promoting linear growth in prepubertal children, growth hormone is often described as having anabolic, lipolytic, and diabetogenic properties. These descriptions are based on the results of diverse short-term studies of humans, animals, and isolated tissues, many of which involved the use of large doses of growth hormone. Until the production of growth hormone by recombinant-DNA methods began, the small supply of pituitary-derived human growth hormone limited its use to the treatment of children with growth hormone deficiency. The wide availability of synthetic human growth hormone has made possible long-term studies of other potentially beneficial uses of growth . . . [Full Text of this Article]

This article has been cited by other articles:

• Dennison, E. M., Syddall, H. E., Rodriguez, S., Voropanov, A., Day, I. N. M., Cooper, C., the Southampton Genetic Epidemiology Research Grou, (2004). Polymorphism in the Growth Hormone Gene, Weight in Infancy, and Adult Bone Mass. J. Clin. Endocrinol. Metab. 89: 4898-4903 [Abstract] [Full Text]  
• Drazen, J. M. (2003). Inappropriate Advertising of Dietary Supplements. NEJM 348: 777-778 [Full Text]  
• Vance, M. L. (2003). Can Growth Hormone Prevent Aging?. NEJM 348: 779-780 [Full Text]  
• Rosen, C. J., Bilezikian, J. P. (2001). Anabolic Therapy for Osteoporosis. J. Clin. Endocrinol. Metab. 86: 957-964 [Abstract] [Full Text]  
• Swerdlow, A. J., Reddingius, R. E., Higgins, C. D., Spoudeas, H. A., Phipps, K., Qiao, Z., Ryder, W. D. J., Brada, M., Hayward, R. D., Brook, C. G. D., Hindmarsh, P. C., Shalet, S. M. (2000). Growth Hormone Treatment of Children with Brain Tumors and Risk of Tumor Recurrence. J. Clin. Endocrinol. Metab. 85: 4444-4449 [Abstract] [Full Text]  
• Rosen, C. J. (1999). Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications. Clin. Chem. 45: 1384-1390 [Abstract] [Full Text]  
• Fall, C., Hindmarsh, P., Dennison, E., Kellingray, S., Barker, D., Cooper, C. (1998). Programming of Growth Hormone Secretion and Bone Mineral Density in Elderly Men: A Hypothesis. J. Clin. Endocrinol. Metab. 83: 135-139 [Abstract] [Full Text]  
• Khorram, O., Laughlin, G. A., Yen, S. S. C. (1997). Endocrine and Metabolic Effects of Long-Term Administration of [Nle27]Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women. J. Clin. Endocrinol. Metab. 82: 1472-1479 [Abstract] [Full Text]  
• Kirk, S. E., Gertz, B. J., Schneider, S. H., Hartman, M. L., Pezzoli, S. S., Wittreich, J. M., Krupa, D. A., Seibold, J. R., Thorner, M. O. (1997). Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men. J. Clin. Endocrinol. Metab. 82: 1154-1159 [Abstract] [Full Text]  
• Committee on Drugs and Committee on Bioethics, (1997). Considerations Related to the Use of Recombinant Human Growth Hormone in Children. Pediatrics 99: 122-129 [Abstract] [Full Text]  
• Bausell, R. B. (1990). Selling Science Down the Drain. Eval Health Prof 13: 394-404